ClinPhone will be exhibiting its complete range of clinical trial technology services at the 18th Annual DIA Euro Meeting.
(February 24, 2005) ClinPhone, the global leader in clinical technology solutions, will be exhibiting its complete range of clinical trial technology services at the 18th DIA Annual Euro Meeting, March 6–8 2006, Les Palais des Congres, Paris. Technologies being showcased include ePRO (Electronic Patient Reported Outcomes), ClinPhone's integration suite for Electronic Data Capture Systems (EDC) and Clinical Trial Management Software (CTMS), Randomization and Medication Management solutions. ClinPhone will also be debuting its recently launched Web-based Clinical Trial Management System (CTMS) at booths #53, 54 and 63.
Showcasing at DIA Europe is ClinPhone's solution for real-time electronic patient reported outcomes data. The 21 CFR part 11 compliant technology addresses concerns over limitations on data quality and integrity of paper diaries and questionnaires, by utilizing Interactive Voice Response (IVR) systems. ClinPhone ePRO is simple and intuitive to use, offering unparalleled diary compliance, study site access to patient data and simultaneous application in an unlimited numbers of languages and countries. ClinPhone will be presenting on electronic Patient Reported Outcomes on Wednesday 8 March (Track 6, ePRO tools between clinical research needs, technical opportunities and patient needs). Bill Byrom, Product Strategy Director at ClinPhone will be conducting a further ePRO presentation "Innovative ePRO Applications and their Contributions to Clinical Trials" during the show.
Also being demonstrated at booths #53, 54 and 63 is ClinPhone integration technology for EDC and CTMS systems. This offers customers a flexible interface between ClinPhone's real-time trial management systems and their EDC and/or CTMS software. This application creates an environment where critical randomization and dispensing data are seamlessly shared between systems in real-time. Unlike other integration solutions, ClinPhone Connect enables data to originate in either system and also offers protocol-specific integration touch-points.
ClinPhone will also be introducing the recently-launched TrialWorks® Web 2005, its innovative, globally scalable web-based CTMS. This system will be deployed by pharmaceutical, biotech and CRO organizations for the day-to-day tracking and reporting of regulatory and clinical information. The new Web-based version will be offered alongside TrialWorks® by ClinPhone v4.5 and ClinPhone's TrialWorks e-Service, enabling ClinPhone to offer its customers the "total" clinical trial management solution.
Other clinical trial solutions being demonstrated at the show include Randomization and Medication Management services. ClinPhone provides automated logistics management and drug supply chain management for clinical trials. The supply processes are controlled by a central computer accessed via telephone (IVR) and web (IWR) interfaces. ClinPhone's sophisticated medication management algorithms are the subject of continued research and development to optimize medication supply chain processes and provide the greatest medication savings and the most robust inventory control.
Patrick Hughes, Strategic Business Development and Marketing Director at ClinPhone, comments: "We are excited to be demonstrating our full range of clinical trial technology solutions at DIA Europe. ClinPhone has an unrivalled track record of innovation in the field of clinical trial management and we welcome this opportunity to unveil our services which offer centralized trial support to the global biopharmaceutical industry."
For further information on ClinPhone's clinical trial management solutions, please visit ClinPhone at booths #53, 54 and 63, 18th DIA Annual Euro Meeting, March 6–8 2006, Le Palais des Congres, Paris, France, or alternatively visit www.clinphone.com or email info@clinphone.com.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
Zerlasiran Achieves Significant Sustained Reduction in Lipoprotein(a) Levels with Infrequent Dosing
November 20th 2024Zerlasiran, a novel siRNA therapy, demonstrated over 80% sustained reductions in lipoprotein(a) levels with infrequent dosing in the Phase II ALPACAR-360 trial, highlighting its potential as a safe and effective treatment for patients at high risk of cardiovascular disease.